Qifa Liu
Nanfang Hospital, Southern Medical University · Department of Hematology,Nanfang Hospital, Southern Medical University · Department of Hematology Nanfang Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Qifa Liu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:23 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT07636486 · Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological MalignanciesNanfang Hospital, Southern Medical University · not yet recruiting · Luspatercept, Epoetin, Poor Erythroid Engraftment · principal investigator
- Ph2/Ph3NCT07539779 · Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe MyelofibrosisNanfang Hospital, Southern Medical University · not yet recruiting · Luspatercept, Poor Erythroid Engraftment, Hematological Malignancies · principal investigator
- Ph3NCT07203352 · Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALLNanfang Hospital, Southern Medical University · recruiting · Acute Lymphoblastic Leukemia · principal investigator
- Ph2/Ph3NCT07052422 · VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCTNanfang Hospital, Southern Medical University · not yet recruiting · Older Patients, Myeloid Malignancies, Conditioning · principal investigator
- Ph3NCT05457361 · VAH Versus VA for Salvage Therapy of R/R-AMLNanfang Hospital, Southern Medical University · unknown · Venetoclax Combined With Azacitidine Plus Homoharringtonine, Venetoclax Combined With Azacitidine · principal investigator
- Ph2/Ph3NCT05453552 · G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCTNanfang Hospital, Southern Medical University · unknown · Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning · principal investigator
- Ph2NCT05404516 · Combination of Sorafenib With Standard Therapy in Newly Diagnosed Adult CBF AMLNanfang Hospital, Southern Medical University · unknown · Core Binding Factor Acute Myeloid Leukemia · principal investigator
- Ph3NCT05290545 · Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCTNanfang Hospital, Southern Medical University · completed · Hematological Malignancies, Hematopoietic Stem Cell Transplantation · principal investigator
- N/ANCT04788420 · Influence of Co-existing Mutations on Sorafenib Maintenance Therapy After Allo-HSCT for Patients With FLT3-ITD AMLNanfang Hospital, Southern Medical University · completed · Acute Myeloid Leukemia, Acute Myeloid Leukemia With FLT3/ITD Mutation, Hematopoietic Stem Cell Transplantation · principal investigator
- Ph2/Ph3NCT04713956 · G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for RAEB-1,REAB-2 and AML Secondary to MDS Undergoing Allo-HSCTNanfang Hospital, Southern Medical University · unknown · Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning · principal investigator
- Ph2/Ph3NCT04674345 · Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute LeukemiaNanfang Hospital, Southern Medical University · unknown · Acute Leukemia, Relapse, Hematopoietic Stem Cell Transplantation · principal investigator
- N/ANCT04622475 · Efficacy and Safety of FMT Capsule Treating Steroid-refractory GI-aGvHDNanfang Hospital, Southern Medical University · unknown · Steroid-refractory Gastrointestinal Acute Graft Versus Host Disease · principal investigator
- Ph2NCT04424147 · Efficacy and Safety of HVA Regimens as Salvage Treatment in rrAMLNanfang Hospital, Southern Medical University · completed · Refractory Acute Myeloid Leukemia, Relapsed Acute Erythroid Leukemia, Salvage Treatment · principal investigator
- Ph4NCT04203108 · ATG in HLA-matched Sibling HSCT as GVHD ProphylaxisNanfang Hospital, Southern Medical University · unknown · Hematopoietic Stem Cell Transplantation · principal investigator
- Ph2/Ph3NCT04123392 · Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCTNanfang Hospital, Southern Medical University · unknown · TP53, Myeloid Tumors, Conditioning · principal investigator
- Ph2/Ph3NCT04098653 · Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCTNanfang Hospital, Southern Medical University · unknown · Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning, Myeloid Tumors · principal investigator
- Ph2/Ph3NCT03733327 · BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCTNanfang Hospital, Southern Medical University · unknown · Primary Central Nervous System Lymphoma, Autologous Hematopoietic Stem Cell Transplantation, Conditioning · principal investigator
- N/ANCT03733834 · SD vs. NSD Therapy in Elderly AMLNanfang Hospital, Southern Medical University · unknown · Standard Therapy, Non-standard Therapy · principal investigator
- Ph4NCT03689465 · PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease ProphylaxisNanfang Hospital, Southern Medical University · unknown · Hematopoietic Stem Cell Transplantation · principal investigator
- Ph2/Ph3NCT03665480 · The Effect of G-CSF on MRD After Induction Therapy in Newly Diagnosed AMLNanfang Hospital, Southern Medical University · unknown · Granulocyte Colony-stimulating Factor, Minimal Residual Disease, Acute Myeloid Leukemia · principal investigator
- Ph2/Ph3NCT03662087 · HMA+DLI vs DLI Preemptive Therapy Based on MRD for AL Undergoing Allo-HSCTNanfang Hospital, Southern Medical University · unknown · Minimal Residual Disease,Acute Leukemia, Hypomethylating Agents, Donor Lymphocyte Infusion, Allogeneic Hematopoietic Cell Transplantation · principal investigator
- Ph2/Ph3NCT03624530 · Effect of Prophylactic TKI Therapy Post-transplants on Ph+ ALL Undergoing Allo-HSCT With MRD Positive Pre-transplantsNanfang Hospital, Southern Medical University · unknown · Philadelphia Chromosome Positive Acute Lymphocytic Leukemia, Tyrosine Kinase Inhibitor, Minimal Residual Disease · principal investigator
- N/ANCT03620955 · Risk-stratified Therapy Based on Molecular Cytogenetic Aberration and Treatment Response in AMLNanfang Hospital, Southern Medical University · unknown · Risk-directed Therapy, Cytogenetic Abnormality, Molecular Abnormality · principal investigator
- Ph2/Ph3NCT03596892 · Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCTNanfang Hospital, Southern Medical University · unknown · Allogeneic Hematopoietic Stem Cell Transplantation, Conditions, Mixed-lineage-leukemia (MLL)-Rearranged Acute Leukemia · principal investigator
- Ph2/Ph3NCT03564704 · Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALLNanfang Hospital, Southern Medical University · unknown · Leukemia, Leukemia, Acute, Adult Lymphoblastic Lymphoma · study chair
- Ph2/Ph3NCT03530085 · Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCTNanfang Hospital, Southern Medical University · unknown · Acute Myeloid Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning · principal investigator
- Ph2/Ph3NCT03229616 · BUCY+VP-16 vs BUCY Conditioning Regimen for DLBCL Undergoing Auto-HSCTNanfang Hospital, Southern Medical University · unknown · Autologous Hematopoietic Stem Cell Transplantation, Diffuse Large B-cell Lymphoma, Conditioning · principal investigator
- N/ANCT02850822 · Effect of Chemotherapy vs No Chemotherapy Pre-transplant to MDS Undergoing Allo-HSCTNanfang Hospital, Southern Medical University · unknown · Myelodysplastic Syndrome, Chemotherapy · principal investigator
- Ph2/Ph3NCT02744742 · G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo-HSCTNanfang Hospital, Southern Medical University · completed · Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning · principal investigator
- N/ANCT02676856 · Hematopoietic Stem Cell Microtransplantation for in AMLNanfang Hospital, Southern Medical University · unknown · Acute Myeloid Leukemia · principal investigator
- Ph2/Ph3NCT02673008 · MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCTNanfang Hospital, Southern Medical University · completed · Minimal Residual Disease, Donor Lymphocyte Infusion, Hematopoietic Stem Cell Transplantation · principal investigator
- Ph2/Ph3NCT02671708 · IDA+BUCY vs BUCY Conditioning Regimen for Intermediate-risk AML Undergoing Auto-HSCTNanfang Hospital, Southern Medical University · completed · Autologous Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Conditioning · principal investigator
- Ph3NCT02670252 · BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCTNanfang Hospital, Southern Medical University · completed · Allogeneic Hematopoietic Stem Cell Transplantation, Busulfan, Total Body Irradiation · principal investigator
- N/ANCT02643589 · Dose Study of Antithymocyteglobulin in Haploidentical Allogeneic Stem Cell TransplantationNanfang Hospital, Southern Medical University · unknown · Hematopoietic Stem Cell Transplantation · principal investigator
- Ph1/Ph2NCT02543073 · MSC for Treatment of Interstitial Lung Disease After Allo-HSCTNanfang Hospital, Southern Medical University · unknown · Lung Diseases, Interstitial, Hematopoietic Stem Cell Transplantation, Bronchiolitis Obliterans · principal investigator
- N/ANCT02487069 · Allo-HSCT With Alternative Donor in Treatment of Hematologic MalignancyNanfang Hospital, Southern Medical University · completed · Acute Leukemia, Chronic Myeloid Leukemia, Myelodysplastic Syndrome · principal investigator
- Ph2/Ph3NCT02474290 · Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AMLNanfang Hospital, Southern Medical University · completed · Acute Myeloid Leukemia, Hematopoietic Stem Cell Transplantation · principal investigator
- Ph2/Ph3NCT02240992 · MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet EngraftmentNanfang Hospital, Southern Medical University · unknown · Stem Cell Transplantation, Hematopoietic, Poor Graft Function, Delayed Platelet Engraftment · principal investigator
- Ph2/Ph3NCT02241018 · MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHDNanfang Hospital, Southern Medical University · unknown · Acute Graft-versus-host Disease · principal investigator
- Ph2/Ph3NCT02241031 · Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of ThrombocytopeniaNanfang Hospital, Southern Medical University · unknown · Hematological Diseases, Thrombocytopenia · principal investigator
- Ph2NCT02083718 · Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft FunctionNanfang Hospital, Southern Medical University · unknown · Stem Cell Transplantation, Hematopoietic, Poor Graft Function, Hematological Diseases · principal investigator
- Ph2NCT02083731 · MSC for Treatment of CMV InfectionNanfang Hospital, Southern Medical University · unknown · Stem Cell Transplantation, Hematopoietic, CMV Infection, Hematological Diseases · principal investigator
- Ph2NCT01883219 · TKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaNanfang Hospital, Southern Medical University · unknown · Philadelphia Chromosome Positive Acute Lymphocytic Leukemia, Stem Cell Transplantation, Minimal Residual Disease · principal investigator
- Ph4NCT01883180 · ATG in Haploidentical HSCT for Acute Graft-versus-host Disease ProphylaxisNanfang Hospital, Southern Medical University · completed · Hematopoietic Stem Cell Transplantation, Antithymocyte Globulin, Viral Infection · principal investigator
- Ph4NCT01873807 · HD-Idarubicin/Etoposide Intensified Conditioning Regimen Allo-HSCT for Adult ALLNanfang Hospital, Southern Medical University · unknown · Acute Lymphoblastic Leukemia · principal investigator
- Ph2NCT01765660 · Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host DiseaseNanfang Hospital, Southern Medical University · unknown · Chronic Graft-versus-host Disease · principal investigator
- Ph2NCT01765634 · Mesenchymal Stem Cells for Treatment of Refractory Acute Graft-versus-host DiseaseNanfang Hospital, Southern Medical University · unknown · Acute Graft-versus-host Disease · principal investigator
- Ph2NCT01763099 · Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft FailureNanfang Hospital, Southern Medical University · unknown · Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cells, Umbilical Cord Blood · principal investigator
- Ph2NCT01763086 · Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell TransplantNanfang Hospital, Southern Medical University · unknown · Stem Cell Transplantation, Hematopoietic, Mesenchymal Stem Cells, Poor Graft Function · principal investigator
- Ph2/Ph3NCT01457040 · Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic LeukemiaNanfang Hospital, Southern Medical University · completed · Acute Lymphoblastic Leukemia, Stem Cell Transplantation, Hematopoietic · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:23 UTC. The ranking covers the 200 most relevant of 1044 PubMed records, and a shared surname and initials can bring in a namesake. All 1044 on PubMed
- 2,392 citationsRCR 180.8
- 1,422 citationsRCR 77.3
- 763 citationsRCR 33.8
- 406 citationsRCR 24.7
- 358 citationsRCR 18.5
- 300 citationsRCR 13.7
- Randomized Controlled-Feeding Study of Dietary Emulsifier Carboxymethylcellulose Reveals Detrimental Impacts on the Gut Microbiota and Metabolome.Gastroenterology · 2022271 citationsRCR 22.9
- 212 citationsRCR 10.2
- 193 citationsRCR 15.2
- 157 citationsRCR 14.0